Uproleselan sodium. E-selectin antagonist, Treatment of acute myeloid leukemia

IF 0.2 4区医学 Q4 Medicine

Drugs of The Future Pub Date : 2022-01-01 DOI:10.1358/dof.2022.47.8.3440034

P. Becker

引用次数: 0

查看原文本刊更多论文

Uproleselan钠。e -选择素拮抗剂，治疗急性髓性白血病

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drugs of The Future 医学-药学

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions. The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.